Recent Study Saus Pradaxa Has More Side Effects

A new study published in the Journal of Clinical Investigation has concluded that Pradaxa lowers the body’s resistance to a virus and can increase the risk for myocarditis in children and young adults.  In the recent study involving laboratory mice, scientists at the University of North Carolina (UNC) found Pradaxa may actually interfere with certain processes in the body. Pradaxa inhibits thrombin, which is the body’s primary clotting agent, which interfere with the immune system.

Pradaxa does not have a reputation for being the safest drug on the market.  Several lawsuits have been filed alleging that Pradaxa, a drug used to risk the risk of stroke and blood clots in people who have atrial fibrillation, caused them to bleed internally and suffer from a heart attacks or death.

“Our findings show that blocking thrombin reduces the innate immune response to viral information,” says Nigel Mackman, director of the UNC McAllister Heart Institute, who helped conduct the study. “The use of the new generation of blood thinners might increase the risk and severity of flu and myocarditis.”

The findings in the new study do not bode well for Pradaxa.  Since drug’s entry into the market in late 2010, Pradaxa has been heavily criticized for its side effects.

If you or someone you love has suffered an injury caused by Pradaxa, please contact Khorrami, LLP for a private consultation.